Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UNIGUIDE-1 phase 3 trial of UBT251 injection in type 2 diabetes inadequately controlled with diet and exercise alone
CTR20262420Phase 3Active
- Sponsor
- The United Laboratories International Holdings
- Start
- Jul 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of UBT251 in type 2 diabetes mellitus (T2DM), sponsored by The United Laboratories International Holdings. Started Jul 2026; status: active.
02
Drugs
UBT251
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20262420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262420.